D. E. Shaw & Co., Inc. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$3,184,161
-55.7%
936,518
-4.2%
0.00%
-57.1%
Q2 2023$7,187,690
-49.1%
977,917
-28.3%
0.01%
-53.3%
Q1 2023$14,128,761
-26.7%
1,363,780
-16.4%
0.02%
-28.6%
Q4 2022$19,269,409
-7.5%
1,631,618
+64.4%
0.02%
-16.0%
Q3 2022$20,826,000
-37.1%
992,213
-6.9%
0.02%
-35.9%
Q2 2022$33,087,000
-30.7%
1,065,947
-8.4%
0.04%
-13.3%
Q1 2022$47,777,000
+16.3%
1,163,586
+23.1%
0.04%
+32.4%
Q4 2021$41,093,000
+1214.1%
945,338
+1413.9%
0.03%
+1033.3%
Q3 2021$3,127,000
+262.8%
62,445
+356.0%
0.00%
+200.0%
Q2 2021$862,000
-25.9%
13,693
+5.4%
0.00%0.0%
Q4 2020$1,164,000
+85.1%
12,991
+63.3%
0.00%0.0%
Q2 2020$629,000
-76.2%
7,954
-82.6%
0.00%
-75.0%
Q1 2020$2,641,000
-49.7%
45,657
-53.1%
0.00%
-33.3%
Q4 2019$5,252,000
-12.8%
97,358
-15.5%
0.01%
-14.3%
Q3 2019$6,023,000
+220.4%
115,215
+196.1%
0.01%
+250.0%
Q2 2019$1,880,000
-43.2%
38,917
-40.6%
0.00%
-50.0%
Q1 2019$3,308,000
-44.5%
65,472
-34.9%
0.00%
-50.0%
Q4 2018$5,962,000
-27.9%
100,575
-19.9%
0.01%
-20.0%
Q3 2018$8,266,000
+16.3%
125,573
-10.8%
0.01%
+11.1%
Q2 2018$7,110,000
-24.7%
140,827
-21.4%
0.01%
-30.8%
Q1 2018$9,437,000
-17.3%
179,247
-27.0%
0.01%
-18.8%
Q4 2017$11,412,000
-5.1%
245,579
-17.4%
0.02%
-11.1%
Q3 2017$12,025,000
-5.9%
297,281
-21.1%
0.02%
-14.3%
Q2 2017$12,781,000
+8.6%
376,912
-7.0%
0.02%0.0%
Q1 2017$11,770,000
-45.7%
405,311
-38.6%
0.02%
-43.2%
Q4 2016$21,668,000
+28.8%
659,797
+23.6%
0.04%
+23.3%
Q3 2016$16,826,000
-29.0%
533,649
-36.7%
0.03%
-31.8%
Q2 2016$23,693,000
-26.9%
842,573
-5.5%
0.04%
-24.1%
Q1 2016$32,420,000
-5.9%
891,876
+3.6%
0.06%
+13.7%
Q4 2015$34,436,000
+58.7%
860,696
+13.0%
0.05%
+59.4%
Q3 2015$21,703,000
+1.7%
761,786
+17.6%
0.03%0.0%
Q2 2015$21,344,000
+22.2%
647,758
+6.6%
0.03%
+18.5%
Q1 2015$17,469,000
+14.3%
607,419
+8.3%
0.03%
+35.0%
Q4 2014$15,279,000
+37.8%
561,118
+7.8%
0.02%
+42.9%
Q3 2014$11,091,000
+0.6%
520,476
+6.1%
0.01%
-6.7%
Q2 2014$11,022,000
-5.7%
490,747
+6.1%
0.02%
-11.8%
Q1 2014$11,689,000
+7.5%
462,548
-2.2%
0.02%
+13.3%
Q4 2013$10,874,000
+21.9%
472,974
+1.0%
0.02%
+7.1%
Q3 2013$8,917,000
+23.5%
468,070
-6.5%
0.01%0.0%
Q2 2013$7,222,000500,8260.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders